A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial
Mahn‐Won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Kiyuk Chang(St. Mary's Hospital), Ki‐Bae Seung, Ki‐Dong Yoo(The Catholic University of Korea St. Vincent's Hospital), Byung‐Hee Hwang(The Catholic University of Korea Seoul St. Mary's Hospital), Chan Joon Kim(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Youngkeun Ahn(Chonnam National University Hospital), Min Chul Kim(Chonnam National University), Myung Ho Jeong(Veterans Health Service Medical Center), Chul‐Soo Park(Catholic University of Korea), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Doo‐Soo Jeon(University of Ulsan), Eun Ho Choo(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 27
Related Papers
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages
|Experimental & Molecular Medicine|2014|548